Taken together, we demonstrated that glucose metabolic abnormalities and insulin resistance were developed in IUGR offsprings, in which reduction of GLUT4 expression possibly mediated by suppression of PI3K/Akt signaling via PPARγ-induced PTEN upregulation was involved. The gene discussed is SLC2A4; the disease is fetal growth restriction.